Cargando…
The Caribbean Community Clinical Oncology Workforce: Analyzing Where We Are Today and Projecting for Tomorrow
PURPOSE: To analyze the current physician clinical oncological workforce within the CARICOM full member states with an aim to make recommendations for building capacity. METHODS: A questionnaire was prepared and emailed to professionals working in oncology in 14 CARICOM full member countries. It was...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925012/ https://www.ncbi.nlm.nih.gov/pubmed/29849631 http://dx.doi.org/10.1155/2018/7286281 |
Sumario: | PURPOSE: To analyze the current physician clinical oncological workforce within the CARICOM full member states with an aim to make recommendations for building capacity. METHODS: A questionnaire was prepared and emailed to professionals working in oncology in 14 CARICOM full member countries. It was designed to identify the number of specialists providing hematology, medical oncology, and radiotherapy services. RESULTS: Ten countries (71.4%) supplied information. Oncology services were insufficient in the majority of countries. Hematology proved to be the most adequately staffed with six countries (60%) having the recommended number of specialists. Medical oncology services were deficient in five countries (50%). Radiation oncology services were the most limited with nine countries (90%) unable to provide the required quota of specialists. The majority of the workforce consisted of nonnationals (55%). The remaining practitioners were nationals, and of these 50% were regionally trained. Oncological care was primarily offered within the public sector. CONCLUSION: Oncological staffing within the CARICOM full member states is insufficient to meet the demands of the current population. Encouraging training through locoregional or international programs is key to obtaining the numbers required. Cancer registries will help provide data to influence public policy and improve the oncological healthcare system. |
---|